Announcements
CV6 Named Finalist in Two Belfast Chamber Business Awards in Partnership With Bank of Ireland
CV6 is a finalist for Business Innovation, sponsored by Kingsbridge Healthcare Group, and Team of the Year, sponsored by Cathedral Quarter BID.
CV6 Announces Initiation of Patient Dosing in CV6-168 Phase 1a Clinical Trial
CV6 Therapeutics (NI) Ltd. (“CV6”) today announced the successful dosing of the second patient in its Phase 1a study evaluating CV6-168 + infusional 5-fluorouracil (5-FU) in cancer patients.